Affiliated to ZHEJIANG EXPRESS (00576) to enter into a contract for digital transformation and smart upgrade project.
Zhejiang Hu Han Yong (00576) announced that on January 22, 2025, the company's non-wholly owned subsidiary in Jiang...
ZHEJIANG EXPRESS (00576) announced that on January 22, 2025, the company's non-wholly owned subsidiary, Zhejiang Intelligent Transportation, signed a contract for the digital transformation and upgrade (Phase I) of the highway infrastructure with Hangning Company, Beixiang Datongdao Company, Traffic Group, and Hangrao Company's related branches and management offices. Zhejiang Intelligent Transportation was appointed to provide software development services for monitoring congestion at toll booths and handling oversized transportation at toll booths. Zhejiang Intelligent Transportation also signed a contract with Hangning Company for the intelligent upgrade and renovation (Phase II) of Hangning Highway, appointing them to provide services for the construction information release platform for the intelligent upgrade and renovation of Hangning Highway.
Related Articles

Robotechnik Intelligent Technology (03757) plans a global offering of 11.876 million shares, introducing cornerstone investors including Temasek and E Fund.

Hong Kong Stock Concept Tracker | AICC2026 Artificial Intelligence Computing Conference Will Be Held; Institutions Suggest Continued Focus on Computing Power Services, Domestic Chips, etc. (with Concept Stocks)

CUTIA-B(02487): CU-40102 (topical finasteride spray) receives marketing approval from the Pharmaceutical Administration Bureau of Macau
Robotechnik Intelligent Technology (03757) plans a global offering of 11.876 million shares, introducing cornerstone investors including Temasek and E Fund.

Hong Kong Stock Concept Tracker | AICC2026 Artificial Intelligence Computing Conference Will Be Held; Institutions Suggest Continued Focus on Computing Power Services, Domestic Chips, etc. (with Concept Stocks)

CUTIA-B(02487): CU-40102 (topical finasteride spray) receives marketing approval from the Pharmaceutical Administration Bureau of Macau

RECOMMEND





